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ABSTRACT 
Introduction: Determination of the D/L-arabinitol ratio in urine appears to be a useful diagnostic test to indicate 
overgrowth of Candida yeast. The aim of this study was to find out whether levels of D/L-arabinitol ratio in the urine of 
children with  autism are heightened. 
Material and methods: D/L-arabinitol ratio in urine was determined by capillary gas chromatography with electron  
capture detection (GC-ECD). Urine samples were collected from 83 autistic children  (2.5–16 years old) and from 50 
healthy children (1.5-16 years old). 
Results: (16.87%) of autistic children under study had an elevated D/L ratio in urine (>4.25). For 8 of them, the stated 
norm  was  exceeded less than twice (D/L: 4.39-6.98); for 4 of them the levels of  D/L-arabinitol were higher than cutoff 
limit 2-3 times (D/L: 8.57-11.6); for 1 child the norm was  exceeded over 5-times (D/L: 21.76); 1 child had a highly 
rebounding value (D/L: 89.13).         
Conclusion: Some of the autistic children show  a raised D/L- arabinitol ratio in urine. Such percentage, in comparison to 
that reported in literature  for other hospitalized patients, is lower than in the case of hematological, cardiac diseases and 
cancer, but higher than in the case of children from intensive care unit and persons after long term antibiotic therapies.  
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1. Introduction   
Autism is a pervasive developmental disorder characterized by impaired social interaction and communication 
and repetitive behaviour, which influences brain cells as well as the digestive and immune systems [1, 2]. There is still 
very little known about its causes.  Most probably there are several of them - genetic, metabolic and environmental 
(exposure to toxic substances, oxidative stress, nutritional deficiencies, improper diet, excessive intake of antibiotics) [3-6].  
One of the hypotheses presumes that autism can result from metabolism disorders [3, 7]. According to this 
theory, it can be caused by exogenous peptides and their influence on neurotransmission in the central nervous system. 
Those peptides probably originate from incomplete decomposition of some foods and the proteins they contain, especially 
gluten and casein. Casein is digested in the stomach to form peptides called casomorphines, which possess opioid-like 
activity. Similar peptides resulting from gluten digestion are called glutenomorphins [7-8]. Urine analyses show that in 70-
80% of  autistic patients the levels of substances with opioid-like properties are increased. It has also been proved that 
deficiency of some vitamins (C, B6, B12, A, E and folic acid) and microelements (zinc, magnesium, selenium, chromium) 
in autistic children can additionally increase the symptoms of autism  [9-11].  
There is an opinion that a form of yeast, Candida species (mainly C. albicans), may exacerbate behavior and health 
problems in autistic individuals, especially those with late-onset autism  [12]. Candida  is a unicellular fungus belonging to 
the yeast family (class Saccharomycetes). It is found in various areas of the body, including the digestive system. In 
certain favorable conditions, e.g. metabolic  acidosis or  intestinal putrefaction, which happen during a bacterial or viral 
infection accompanied by fever, it becomes a pathogen. Immune deficiency accelerates its development. It forms a 
mycelium which grows into surrounding tissues and causes damage to them. The fungus also secretes specific toxins, 
which additionally weakens the immune system and act directly on the central nervous system  [13]. A large number of 
studies have indicated a wide number of abnormalities of the immune system in autism.  Immune deficiencies lead to an 
increased frequency of infections that are almost always treated with antibiotics. As a result, a proliferation of Candida 
yeast and bacteria occur in the gastrointestinal tract. Shaw et al. found the presence of microbial metabolites in the urine 
of autistic patients. Antifungal treatment can result in the improvement of eye contact, speech and concentration in autistic 
persons [14]. D–arabinitol is the main metabolite characteristic of several Candida species. The urine D– to L–arabinitol 
concentration ratio reflects the same ratio in blood  [15,16]. There is evidence that elevated levels of D-arabinitol in urine 
or serum is a positive indication of Candida overgrowth, even if invasive candidiasis is not present [17].  
The aim of this study was to find out whether there are heightened levels of D/L-arabinitol ratio in the urine of 
children with  autism. A  simple method  for  the monitoring of the D/L- arabinitol  ratio in  urine by gas chromatography 
with electron capture detection (GC-ECD) was applied.  
2. Material and methods 
2.1. Participants  
Overnight urine samples were collected from 83 autistic children (2.5–16 years old, 7.16±3.18) who underwent 
rehabilitation in the Navicula-Centre in Lodz. All autistic children were assessed and diagnosed by clinicians  specializing 
in the diagnosis and management of autistic  children from the Navicula. The control group consisted of 50 potentially 
healthy children (1.5-16 years old, 6.94±3.98). All procedures were carried out with the written consent of a parent. The 
study was performed in agreement with the Standards and Ethics in Biological Rhythm Research  [18].
 
An approval was 
given by Committee of Scientific Research Ethics of Polish Mother’s Memorial Hospital – Research Institute in Lodz, 
Poland. 
2.2. Analytical method 
In order to determine the urinary D/L ratio a method of gas chromatography with electron capture detection (GC-ECD) 
was applied. A gas chromatograph-electron capture detector (Agilent Technology) with an autosampler  was used. A 
fused silica column coated with -cyclodextrin layer (-dex 120 Supelco, 30 m length, 0.25 mm diameter and 0.25 m film 
thickness) was applied in order to separate enantiomers. The method measured the D/L ratio from peak areas. The use of 
an internal standard and calculation of the absolute concentration of enantiomers was not required [19]. Typical GC-ECD 
chromatogram of urine is shown in Figure 1. 
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Figure 1. Chromatogram of D/L-arabinitol in urine 
 
2.3. Statistical analysis 
Data were statistically evaluated using statistical analysis package (StatSoft, Polska STATISTICA, version 9.0.). 
The Shapiro–Wilk test was used to check for normal distribution of the results. The Mann-Whitney test was applied to 
check differences in variables in groups. The level of statistical significance was defined as p<0.05. 
3. Results 
 The analyses of D/L-arabinitol ratio were carried out in the urine samples collected from 83 autistic children (80 
males and 3 females) and 50 healthy children (34 males and 16 females). The  applied method  was described  in detail  
in our earlier paper  [19]. The distribution of the variable D/L ratio for the whole group of autistic children and controls was 
not normal at an accepted alpha level (Shapiro–Wilk test probabilities p: 0.00 and 0.03, respectively). The basic  statistical 
parameters for the D/L-arabinitol ratio in the urine of  children under investigation were shown in Table 1.  
 
The calculated probability of Mann-Whitney test (p=0.11) indicates that there are not significant differences 
between the average results of the urinary D/L ratio expressed as medians between the two groups. The maximum value 
for the control group (4.25) was stated as the upper cutoff limit. 14 children (16.87%) had an elevated D/L ratio 
(male/female: 11/3).  For 8 of them, the stated norm  was  exceeded less than twice (D/L: 4.39-6.98); for 4 of them the 
levels of  D/L-arabinitol were higher than cutoff limit 2-3 times (D/L: 8.57-11.6); for 1 child the norm was  exceeded over 5-
times (D/L: 21.76); 1 child had a highly rebounding value (D/L: 89.13).   
 
Table 1. The basic statistical parameters for the D/L-arabinitol ratio in urine  of  children under investigation. 
  
D/L-arabinitol ratio autistic children (n=83) control individuals (n=50) 
median 1.86 2.06 
interquartile range 1.34-2.52 1.61-2.54 
range 0.42-89.13 1.12-4.25 
 
4. Discussion 
The overgrowth of Candida can be caused by a long-term antibiotic therapy, stress, steroids and oral 
contraceptives. The overgrowth of Candida in the gut  can lead to a myriad of symptoms, which include but are not limited 
to: chronic fatigue, especially after an increase in body temperature, depression, gastrointestinal problems such as: 
bloating, gas, intestinal cramps, chronic diarrhea, constipation, or heartburn,  allergies (including both food and airborne)  
[20-22]. When yeasts multiply in the body, toxins which disrupt the work of the central nervous system and immune 
system are released  [21]. Clinical signs of  invasive candidiasis can be unspecific, and the diagnosis is mostly based on 
blood cultures.  However, blood cultures have been assumed to be positive for Candida in only 24 to 60 % of cases [23]. 
Human mammalian cells are capable of producing both D- and L-arabinitol. D-arabinitol, in contrast to L-arabinitol, is 
produced by fungi of the genus Candida. An elevated D/L-arabinitol  ratio is a sensitive sign of invasive candidiasis. The 
D/L-arabinitol ratio is most frequently analyzed by enzymatic assays [24], electrochemical method  [25], liquid 
L 
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chromatography (LC) or LC/mass spectrometry (LC/MS)[26, 27] and gas chromatography (GC) or GC/mass spectrometry  
[15, 28].
 
The enzymatic assays are involved in the maintenance of enzyme activity and false positive results by 
competition reaction [29]. The chromatographic methods are very desirable and  helpful in the diagnosis of disseminated 
candidiasis.  We determined the D/L ratio by gas chromatography  with electron capture detection in the urine samples 
from the autistic and healthy children.  
In our current research  only a proportion of the autistic children under investigation had raised D/L ratio in urine 
(16.87%).  
The D/L - arabinitol ratio is often elevated in patients suffering from serious immunological system diseases. Lehtonen and 
co-authors discovered an elevated D/L ratio in urine among 31.15% of adults suffering from hematological malignancies 
(also patients with acute leukemia) [30]. D/L-arabinitol is a useful diagnostic marker for candidiasis among neutropenic 
patients and among  other high-risk groups. Some papers describe studies of D/L - arabinitol ratio in children’s urine. 
Stradomska and co-authors showed an elevated D/L ratio in urine among 20.29% children with cardiac diseases [31]. 
Elevated D/L ratios in urine were reported among 26 % children with cancer [32]. 11.97 % infants from an intensive care 
unit had an elevated D/L ratio in their urine [33]. However, only 7.84 % children after long-term antibiotic therapies had a 
higher urinary D/L ratio [34].
 
 
5. Conclusions  
          In our current research  a proportion of the autistic children under investigation had raised D/L ratio in urine 
(16.87%). Such percentage, in comparison to that reported in literature  for other hospitalized patients, is lower than in the 
case of hematological, cardiac diseases and cancer, but higher than in the case of children from intensive care unit and 
patients after long term antibiotic therapies [30-34].  
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